PrecisionOS® has received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market InVisionOS™ a patient specific planning tool using Virtual Reality (VR). Surgeons can utilize an Oculus Quest 2 device to undertake preoperative planning with the patented software, which will be accessible in early 2022.
Read morePrecisionOS has received FDA approval to market its virtual reality surgical planning tool.